Ipca Laboratories Ltd. | IPCALAB | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Net Income |
| 2,703 | 2,905 | 5,465 | 7,389 | 13,813 |
Cash flow Operating Act... |
| 2,764 | 3,411 | 4,923 | 5,643 | 10,901 |
Investments in PPE |
| -1,363 | -1,367 | -1,805 | -3,063 | -3,616 |
Cash flow Investing Act... |
| -1,432 | -1,354 | -1,563 | -5,097 | -5,207 |
Dividend Paid |
| 2 | 153 | 154 | 1,217 | 1,015 |
Cash flow Financing Act... |
| -1,591 | -1,304 | -1,832 | -1,305 | -3,058 |
Cash at beginning of period |
| 1,689 | 1,428 | 2,182 | 3,709 | 2,954 |
Cash at end of period |
| 1,430 | 2,182 | 3,709 | 2,954 | 5,590 |
Free Cash Flow |
| 1,401 | 2,044 | 3,117 | 2,580 | 7,286 |